Related Concept Videos
01:29Microbiota of the Respiratory Tract
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more like...
01:22Probiotics
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
01:17Other Pulmonary Disorders
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
01:20Asthma: Pathogenesis and Management
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Limited nesting stress in mice as a model to study neuroimmune relationships in postpartum depression.
Journal of neuroendocrinology·2026
Related Experiment Video
Updated: Jun 3, 2026
09:20
Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Probiotics and lung diseases.
1Brain-Body Institute and Department of Medicine, McMaster University, Hamilton, ON, Canada.
Chest
|April 7, 2011
Summary
Probiotics show promise for immune health, particularly in the respiratory tract, by modulating immune responses. However, clinical trial results are inconsistent, highlighting the need for further research into bacterial interactions and immune signaling for effective therapeutic strategies.
Area of Science:
- Immunology
- Microbiology
- Respiratory Medicine
Background:
- Intestinal commensal bacteria play a crucial role in immune system development and modulation.
- Nonpathogenic bacteria, including probiotics, demonstrate immunomodulatory effects in animal models.
- Intestinal microbes can influence distant sites like the respiratory tract via common mucosal immune responses.
Purpose of the Study:
- To explore the therapeutic potential of probiotics and bacteria-based strategies for immune-related disorders, focusing on respiratory health.
- To review the immunomodulatory effects of probiotics in animal models, particularly concerning allergic airway responses and pathogen protection.
- To identify key immune cells and mechanisms involved in probiotic-mediated immune responses.
Main Methods:
- Review of animal model studies investigating probiotic effects on the immune system.
- Analysis of the role of dendritic cells and regulatory T cells in probiotic-mediated immune responses.
- Evaluation of clinical trial data for probiotics in allergy, asthma, and respiratory infections.
Main Results:
- Animal studies show probiotics can attenuate allergic airway inflammation and protect against respiratory pathogens.
- Dendritic cells are central to translating microbial signals, while regulatory T cells are key effectors in reducing allergic inflammation.
- Clinical trials for probiotics in respiratory conditions have yielded highly variable results.
Conclusions:
- Despite promising animal data, clinical efficacy of probiotics for respiratory health remains inconsistent.
- Further research is needed to understand the interaction between probiotics and the host microbiota.
- Elucidating the dialogue between microbes and the innate immune system is crucial for developing effective bacteria-based therapies for respiratory health.